Contextlogic Inc Valuation

LOGC Stock  USD 7.70  0.05  0.65%   
At this time, the firm appears to be fairly valued. Contextlogic Inc shows a prevailing Real Value of $7.51 per share. The current price of the firm is $7.7. Our model approximates the value of Contextlogic Inc from analyzing the firm fundamentals such as Profit Margin of (2.86) %, return on equity of -0.1, and Current Valuation of 49.66 M as well as examining its technical indicators and probability of bankruptcy. . In general, most investors favor purchasing undervalued instruments and exiting overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Fairly Valued
Today
7.70
Please note that Contextlogic Inc's price fluctuation is somewhat reliable at this time. Calculation of the real value of Contextlogic Inc is based on 3 months time horizon. Increasing Contextlogic Inc's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Contextlogic Inc otc stock is determined by what a typical buyer is willing to pay for full or partial control of Contextlogic. Since Contextlogic Inc is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Contextlogic Inc OTC Stock. However, Contextlogic Inc's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  7.7 Real  7.51 Hype  7.7 Naive  7.47
The real value of Contextlogic Inc OTC Stock, also known as its intrinsic value, is the underlying worth of Contextlogic Inc OTC Stock, which is reflected in its stock price. It is based on Contextlogic Inc's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Contextlogic Inc's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
7.51
Real Value
9.40
Upside
Estimating the potential upside or downside of Contextlogic helps investors to forecast how Contextlogic Inc otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Contextlogic Inc more accurately as focusing exclusively on Contextlogic Inc's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
7.157.678.18
Details
Hype
Prediction
LowEstimatedHigh
5.817.709.59
Details
Naive
Forecast
LowNext ValueHigh
5.597.479.36
Details

Contextlogic Inc Total Value Analysis

Contextlogic is now forecasted to have valuation of 49.66 M with market capitalization of 195.58 M, debt of 5 M, and cash on hands of 38.85 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Contextlogic Inc fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
49.66 M
195.58 M
M
38.85 M

Contextlogic Inc Investor Information

About 64.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.36. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Contextlogic Inc recorded a loss per share of 0.76. The entity had not issued any dividends in recent years. The firm had 1:30 split on the 12th of April 2023. Based on the measurements of operating efficiency obtained from Contextlogic Inc's historical financial statements, Contextlogic is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.

Contextlogic Inc Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Contextlogic Inc has an asset utilization ratio of 27.56 percent. This indicates that the OTC Stock is making $0.28 for each dollar of assets. An increasing asset utilization means that Contextlogic is more efficient with each dollar of assets it utilizes for everyday operations.

Contextlogic Inc Ownership Allocation

Contextlogic Inc holds a total of 26.68 Million outstanding shares. Over half of Contextlogic Inc's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Contextlogic Inc Profitability Analysis

The company reported the previous year's revenue of 43 M. Net Loss for the year was (75 M) with profit before overhead, payroll, taxes, and interest of 1000 K.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Contextlogic Inc's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Contextlogic Inc and how it compares across the competition.

About Contextlogic Inc Valuation

The otc valuation mechanism determines Contextlogic Inc's current worth on a weekly basis. Our valuation model uses a comparative analysis of Contextlogic Inc. We calculate exposure to Contextlogic Inc's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Contextlogic Inc's related companies.
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company was incorporated in 2014 and is headquartered in Lexington, Massachusetts. Logicbio Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 62 people.

8 Steps to conduct Contextlogic Inc's Valuation Analysis

OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Contextlogic Inc's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Contextlogic Inc's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Contextlogic Inc's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Contextlogic Inc's revenue streams: Identify Contextlogic Inc's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Contextlogic Inc's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Contextlogic Inc's growth potential: Evaluate Contextlogic Inc's management, business model, and growth potential.
  • Determine Contextlogic Inc's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Contextlogic Inc's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the otc stock being valued. We also recomment to seek professional assistance to ensure accuracy.

Contextlogic Inc Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding25.7 M
Forward Price Earnings43.8596

Complementary Tools for Contextlogic Inc OTC Stock analysis

When running Contextlogic Inc's price analysis, check to measure Contextlogic Inc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Contextlogic Inc is operating at the current time. Most of Contextlogic Inc's value examination focuses on studying past and present price action to predict the probability of Contextlogic Inc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Contextlogic Inc's price. Additionally, you may evaluate how the addition of Contextlogic Inc to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges